-
1
-
-
84886641249
-
Glial influence on the blood brain barrier
-
Alvarez, J.I., T. Katayama, and A. Prat. 2013. Glial influence on the blood brain barrier. Glia. 61:1939-1958.http://dx.doi.org/10.1002/glia.22575
-
(2013)
Glia
, vol.61
, pp. 1939-1958
-
-
Alvarez, J.I.1
Katayama, T.2
Prat, A.3
-
2
-
-
65249141706
-
Gaining entry to an uninflamed brain
-
Axtell, R.C., and L. Steinman. 2009. Gaining entry to an uninflamed brain. Nat. Immunol. 10:453-455. http://dx.doi.org/10.1038/ni0509-453
-
(2009)
Nat. Immunol.
, vol.10
, pp. 453-455
-
-
Axtell, R.C.1
Steinman, L.2
-
3
-
-
0034332965
-
CD4(+)CD45RO(+)CD49d(high) cells are involved in the pathogenesis of relapsing-remitting multiple sclerosis
-
Barrau, M.A., X. Montalban, I. Sáez-Torres, L. Brieva, N. Barberá and E.M. Martínez-Cáceres. 2000. CD4(+)CD45RO(+)CD49d(high) cells are involved in the pathogenesis of relapsing-remitting multiple sclerosis. J. Neuroimmunol. 111:215-223. http://dx.doi.org/10.1016/S0165-5728(00)00357-X
-
(2000)
J. Neuroimmunol.
, vol.111
, pp. 215-223
-
-
Barrau, M.A.1
Montalban, X.2
Sáez-Torres, I.3
Brieva, L.4
Barberá, N.5
Martínez-Cáceres, E.M.6
-
4
-
-
60549086393
-
Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity
-
Bauer, M., C. Brakebusch, C. Coisne, M. Sixt, H. Wekerle, B. Engelhardt, and R. Fässler. 2009. Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc. Natl. Acad. Sci. USA. 106:1920-1925. http://dx.doi.org/10.1073/pnas.0808909106
-
(2009)
Proc. Natl. Acad. Sci. USA.
, vol.106
, pp. 1920-1925
-
-
Bauer, M.1
Brakebusch, C.2
Coisne, C.3
Sixt, M.4
Wekerle, H.5
Engelhardt, B.6
Fässler, R.7
-
5
-
-
84861022041
-
Risk of natalizumab-associated progressive multifocal leukoencephalopathy
-
Bloomgren, G., S. Richman, C. Hotermans, M. Subramanyam, S. Goelz, A. Natarajan, S. Lee, T. Plavina, J.V. Scanlon, A. Sandrock, and C. Bozic. 2012. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N. Engl. J. Med. 366:1870-1880. http://dx.doi.org/10.1056/NEJMoa1107829
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 1870-1880
-
-
Bloomgren, G.1
Richman, S.2
Hotermans, C.3
Subramanyam, M.4
Goelz, S.5
Natarajan, A.6
Lee, S.7
Plavina, T.8
Scanlon, J.V.9
Sandrock, A.10
Bozic, C.11
-
6
-
-
84902206179
-
Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity
-
Breuer, J., N. Schwab, T. Schneider-Hohendorf, M. Marziniak, H. Mohan, U. Bhatia, C.C. Gross, B.E. Clausen, C. Weishaupt, T.A. Luger, et al. 2014. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann. Neurol. 75:739-758. http://dx.doi.org/10.1002/ana.24165
-
(2014)
Ann. Neurol.
, vol.75
, pp. 739-758
-
-
Breuer, J.1
Schwab, N.2
Schneider-Hohendorf, T.3
Marziniak, M.4
Mohan, H.5
Bhatia, U.6
Gross, C.C.7
Clausen, B.E.8
Weishaupt, C.9
Luger, T.A.10
-
7
-
-
0032536046
-
Chemokines and the arrest of lymphocytes rolling under flow conditions
-
Campbell, J.J., J. Hedrick, A. Zlotnik, M.A. Siani, D.A. Thompson, and E.C. Butcher. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science. 279:381-384. http://dx.doi.org/10.1126/science.279.5349.381
-
(1998)
Science
, vol.279
, pp. 381-384
-
-
Campbell, J.J.1
Hedrick, J.2
Zlotnik, A.3
Siani, M.A.4
Thompson, D.A.5
Butcher, E.C.6
-
8
-
-
70350718157
-
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the bloodbrain barrier in vivo in an animal model of multiple sclerosis
-
Coisne, C., W. Mao, and B. Engelhardt. 2009. Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the bloodbrain barrier in vivo in an animal model of multiple sclerosis. J. Immunol. 182:5909-5913. http://dx.doi.org/10.4049/jimmunol.0803418
-
(2009)
J. Immunol.
, vol.182
, pp. 5909-5913
-
-
Coisne, C.1
Mao, W.2
Engelhardt, B.3
-
9
-
-
84897010288
-
Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM)
-
Dagur, P.K., A. Biancotto, E. Stansky, H.N. Sen, R.B. Nussenblatt, and J.P. McCoy. 2014. Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM). Clin. Immunol. 152:36-47. http://dx.doi.org/10.1016/j.clim.2014.01.009
-
(2014)
Clin. Immunol.
, vol.152
, pp. 36-47
-
-
Dagur, P.K.1
Biancotto, A.2
Stansky, E.3
Sen, H.N.4
Nussenblatt, R.B.5
McCoy, J.P.6
-
10
-
-
33745038011
-
CLEAR Multinational Study Group. CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial
-
Dubertret, L., W. Sterry, J.D. Bos, S. Chimenti, S. Shumack, C.G. Larsen, N.H. Shear, and K.A. Papp. CLEAR Multinational Study Group. 2006. CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial. Br. J. Dermatol. 155:170-181. http://dx.doi.org/10.1111/j.1365-2133.2006.07344.x
-
(2006)
Br. J. Dermatol.
, vol.155
, pp. 170-181
-
-
Dubertret, L.1
Sterry, W.2
Bos, J.D.3
Chimenti, S.4
Shumack, S.5
Larsen, C.G.6
Shear, N.H.7
Papp, K.A.8
-
11
-
-
84869885852
-
Capture, crawl, cross: the T cell code to breach the blood-brain barriers
-
Engelhardt, B., and R.M. Ransohoff. 2012. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 33:579-589. http://dx.doi.org/10.1016/j.it.2012.07.004
-
(2012)
Trends Immunol
, vol.33
, pp. 579-589
-
-
Engelhardt, B.1
Ransohoff, R.M.2
-
12
-
-
73449115641
-
The blood-brain and the bloodcerebrospinal fluid barriers: function and dysfunction
-
Engelhardt, B., and L. Sorokin. 2009. The blood-brain and the bloodcerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. 31:497-511. http://dx.doi.org/10.1007/s00281-009-0177-0
-
(2009)
Semin. Immunopathol.
, vol.31
, pp. 497-511
-
-
Engelhardt, B.1
Sorokin, L.2
-
13
-
-
84863713142
-
Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS
-
Flanagan, K., K. Fitzgerald, J. Baker, K. Regnstrom, S. Gardai, F. Bard, S. Mocci, P. Seto, M. You, C. Larochelle, et al. 2012. Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS. PLoS ONE. 7:e40443. http://dx.doi.org/10.1371/journal.pone.0040443
-
(2012)
PLoS ONE
, vol.7
-
-
Flanagan, K.1
Fitzgerald, K.2
Baker, J.3
Regnstrom, K.4
Gardai, S.5
Bard, F.6
Mocci, S.7
Seto, P.8
You, M.9
Larochelle, C.10
-
14
-
-
84855218290
-
Autoimmune disease in the brain-how to spot the culprits and how to keep them in check
-
Flüel, A., C. Schler, F. Lüder, and F. Odoardi. 2011. Autoimmune disease in the brain-how to spot the culprits and how to keep them in check. J. Neurol. Sci. 311:S3-S11.
-
(2011)
J. Neurol. Sci.
, vol.311
-
-
Flüel, A.1
Schler, C.2
Lüder, F.3
Odoardi, F.4
-
15
-
-
0026022298
-
Muromonab CD-3: a review of its pharmacology, pharmacokinetics, and clinical use in transplantation
-
Hooks, M.A., C.S. Wade, and W.J. Millikan Jr. 1991. Muromonab CD-3: a review of its pharmacology, pharmacokinetics, and clinical use in transplantation. Pharmacotherapy. 11:26-37.
-
(1991)
Pharmacotherapy
, vol.11
, pp. 26-37
-
-
Hooks, M.A.1
Wade, C.S.2
Millikan Jr., W.J.3
-
16
-
-
70149099765
-
Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis
-
Huang, Y.-H., A.L. Zozulya, C. Weidenfeller, I. Metz, D. Buck, K.V. Toyka, W. Brük, and H. Wiendl. 2009. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Ann. Neurol. 66:171-183. http://dx.doi.org/10.1002/ana.21705
-
(2009)
Ann. Neurol.
, vol.66
, pp. 171-183
-
-
Huang, Y.-H.1
Zozulya, A.L.2
Weidenfeller, C.3
Metz, I.4
Buck, D.5
Toyka, K.V.6
Brük, W.7
Wiendl, H.8
-
17
-
-
34948909646
-
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
-
Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13:1173-1175. http://dx.doi.org/10.1038/nm1651
-
(2007)
Nat. Med.
, vol.13
, pp. 1173-1175
-
-
Kebir, H.1
Kreymborg, K.2
Ifergan, I.3
Dodelet-Devillers, A.4
Cayrol, R.5
Bernard, M.6
Giuliani, F.7
Arbour, N.8
Becher, B.9
Prat, A.10
-
18
-
-
33646468932
-
Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis
-
Kerfoot, S.M., M.U. Norman, B.M. Lapointe, C.S. Bonder, L. Zbytnuik, and P. Kubes. 2006. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J. Immunol. 176:6225-6234. http://dx.doi.org/10.4049/jimmunol.176.10.6225
-
(2006)
J. Immunol.
, vol.176
, pp. 6225-6234
-
-
Kerfoot, S.M.1
Norman, M.U.2
Lapointe, B.M.3
Bonder, C.S.4
Zbytnuik, L.5
Kubes, P.6
-
19
-
-
84874859809
-
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses
-
Kieseier, B.C., O. Stüve, T. Dehmel, N. Goebels, V.I. Leussink, A.K. Mausberg, M. Ringelstein, B. Turowski, O. Aktas, G. Antoch, and H.-P. Hartung. 2013. Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses. JAMA Neurol. 70:390-393. http://dx.doi.org/10.1001/jamaneurol.2013.668
-
(2013)
JAMA Neurol
, vol.70
, pp. 390-393
-
-
Kieseier, B.C.1
Stüve, O.2
Dehmel, T.3
Goebels, N.4
Leussink, V.I.5
Mausberg, A.K.6
Ringelstein, M.7
Turowski, B.8
Aktas, O.9
Antoch, G.10
Hartung, H.-P.11
-
20
-
-
67650032747
-
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells
-
Kivisk, P., B.C. Healy, V. Viglietta, F.J. Quintana, M.A. Hootstein, H.L. Weiner, and S.J. Khoury. 2009. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology. 72:1922-1930. http://dx.doi.org/10.1212/WNL.0b013e3181a8266f
-
(2009)
Neurology
, vol.72
, pp. 1922-1930
-
-
Kivisk, P.1
Healy, B.C.2
Viglietta, V.3
Quintana, F.J.4
Hootstein, M.A.5
Weiner, H.L.6
Khoury, S.J.7
-
21
-
-
81755179424
-
How do immune cells overcome the blood-brain barrier in multiple sclerosis
-
Larochelle, C., J.I. Alvarez, and A. Prat. 2011. How do immune cells overcome the blood-brain barrier in multiple sclerosis FEBS Lett. 585:3770-3780. http://dx.doi.org/10.1016/j.febslet.2011.04.066
-
(2011)
FEBS Lett
, vol.585
, pp. 3770-3780
-
-
Larochelle, C.1
Alvarez, J.I.2
Prat, A.3
-
22
-
-
84867735795
-
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system
-
Larochelle, C., R. Cayrol, H. Kebir, J.I. Alvarez, M.-A. Luyer, I. Ifergan,. Viel, L. Bourbonnie, D. Beauseigle, S. Terouz, et al. 2012. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain. 135: 2906-2924. http://dx.doi.org/10.1093/brain/aws212
-
(2012)
Brain
, vol.135
, pp. 2906-2924
-
-
Larochelle, C.1
Cayrol, R.2
Kebir, H.3
Alvarez, J.I.4
Luyer, M.-A.5
Ifergan, I.6
Viel, É.7
Bourbonnie, L.8
Beauseigle, D.9
Terouz, S.10
-
23
-
-
0342906187
-
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination
-
Lucchinetti, C., W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47:707-717. http://dx.doi.org/10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
-
(2000)
Ann. Neurol.
, vol.47
, pp. 707-717
-
-
Lucchinetti, C.1
Brück, W.2
Parisi, J.3
Scheithauer, B.4
Rodriguez, M.5
Lassmann, H.6
-
24
-
-
84896716343
-
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up
-
Melis, M., E. Cocco, J. Frau, L. Lorefice, G. Fenu, G. Coghe, M. Mura, and M.G. Marrosu. 2013. Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up. Neurol. Sci. 35:401-408.
-
(2013)
Neurol. Sci.
, vol.35
, pp. 401-408
-
-
Melis, M.1
Cocco, E.2
Frau, J.3
Lorefice, L.4
Fenu, G.5
Coghe, G.6
Mura, M.7
Marrosu, M.G.8
-
25
-
-
0037083641
-
Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors
-
Piccio, L., B. Rossi, E. Scarpini, C. Laudanna, C. Giagulli, A.C. Issekutz, D. Vestweber, E.C. Butcher, and G. Constantin. 2002. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J. Immunol. 168:1940-1949. http://dx.doi.org/10.4049/jimmunol.168.4.1940
-
(2002)
J. Immunol.
, vol.168
, pp. 1940-1949
-
-
Piccio, L.1
Rossi, B.2
Scarpini, E.3
Laudanna, C.4
Giagulli, C.5
Issekutz, A.C.6
Vestweber, D.7
Butcher, E.C.8
Constantin, G.9
-
26
-
-
28544436950
-
Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria
-
Polman, C.H., S.C. Reingold, G. Edan, M. Filippi, H.-P. Hartung, L. Kappos, F.D. Lublin, L.M. Metz, H.F. McFarland, P.W. O'Connor, et al. 2005. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58:840-846. http://dx.doi.org/10.1002/ana.20703
-
(2005)
Ann. Neurol.
, vol.58
, pp. 840-846
-
-
Polman, C.H.1
Reingold, S.C.2
Edan, G.3
Filippi, M.4
Hartung, H.-P.5
Kappos, L.6
Lublin, F.D.7
Metz, L.M.8
McFarland, H.F.9
O'Connor, P.W.10
-
27
-
-
33644584352
-
AFFIRM Investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
-
Polman, C.H., P.W. O'Connor, E. Havrdova, M. Hutchinson, L. Kappos, D.H. Miller, J.T. Phillips, F.D. Lublin, G. Giovannoni, A. Wajgt, et al. AFFIRM Investigators. 2006. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354:899-910. http://dx.doi.org/10.1056/NEJMoa044397
-
(2006)
N. Engl. J. Med.
, vol.354
, pp. 899-910
-
-
Polman, C.H.1
O'Connor, P.W.2
Havrdova, E.3
Hutchinson, M.4
Kappos, L.5
Miller, D.H.6
Phillips, J.T.7
Lublin, F.D.8
Giovannoni, G.9
Wajgt, A.10
-
28
-
-
0033540112
-
Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice
-
Ringelmann, B., C. Rer, R. Hallmann, M. Maley, M. Davies, M. Grounds, and L. Sorokin. 1999. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp. Cell Res. 246:165-182. http://dx.doi.org/10.1006/excr.1998.4244
-
(1999)
Exp. Cell Res.
, vol.246
, pp. 165-182
-
-
Ringelmann, B.1
Rer, C.2
Hallmann, R.3
Maley, M.4
Davies, M.5
Grounds, M.6
Sorokin, L.7
-
29
-
-
84855475637
-
Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE
-
Rothhammer, V., S. Heink, F. Petermann, R. Srivastava, M.C. Claussen, B. Hemmer, and T. Korn. 2011. Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE. J. Exp. Med. 208:2465-2476. http://dx.doi.org/10.1084/jem.20110434
-
(2011)
J Exp. Med.
, vol.208
, pp. 2465-2476
-
-
Rothhammer, V.1
Heink, S.2
Petermann, F.3
Srivastava, R.4
Claussen, M.C.5
Hemmer, B.6
Korn, T.7
-
30
-
-
84906564519
-
α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets
-
Rothhammer, V., A. Muschaweckh, G. Gasteiger, F. Petermann, S. Heink, D.H. Busch, M. Heikenwder, B. Hemmer, I. Drexler, and T. Korn. 2014. 4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets. Acta Neuropathol Commun. 2:27. http://dx.doi.org/10.1186/2051-5960-2-27
-
(2014)
Acta Neuropathol Commun
, vol.2
, pp. 27
-
-
Rothhammer, V.1
Muschaweckh, A.2
Gasteiger, G.3
Petermann, F.4
Heink, S.5
Busch, D.H.6
Heikenwder, M.7
Hemmer, B.8
Drexler, I.9
Korn, T.10
-
31
-
-
84858405029
-
Efficacy of anti-interleukin-2 receptor antibody (daclizumab) in reducing the incidence of acute rejection after renal transplantation
-
Saghafi, H., K. Rahbar, A. Nobakht Haghighi, M. Qoreishi, and F. Safdari. 2012. Efficacy of anti-interleukin-2 receptor antibody (daclizumab) in reducing the incidence of acute rejection after renal transplantation. Nephrourol Mon. 4:475-477. http://dx.doi.org/10.5812/numonthly.1806
-
(2012)
Nephrourol Mon
, vol.4
, pp. 475-477
-
-
Saghafi, H.1
Rahbar, K.2
Nobakht Haghighi, A.3
Qoreishi, M.4
Safdari, F.5
-
32
-
-
78649600894
-
Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis
-
Schneider-Hohendorf, T., M.-P. Stenner, C. Weidenfeller, A.L. Zozulya, O.J. Simon, N. Schwab, and H. Wiendl. 2010. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur. J. Immunol. 40:3581-3590. http://dx.doi.org/10.1002/eji.201040558
-
(2010)
Eur. J. Immunol.
, vol.40
, pp. 3581-3590
-
-
Schneider-Hohendorf, T.1
Stenner, M.-P.2
Weidenfeller, C.3
Zozulya, A.L.4
Simon, O.J.5
Schwab, N.6
Wiendl, H.7
-
33
-
-
77954521172
-
An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis
-
Schwab, N., A.L. Zozulya, B.C. Kieseier, K.V. Toyka, and H. Wiendl. 2010. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. J. Immunol. 184:5368-5374. http://dx.doi.org/10.4049/jimmunol.0903662
-
(2010)
J. Immunol.
, vol.184
, pp. 5368-5374
-
-
Schwab, N.1
Zozulya, A.L.2
Kieseier, B.C.3
Toyka, K.V.4
Wiendl, H.5
-
34
-
-
84858146335
-
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control
-
discussion 465
-
Schwab, N., J.C. Ulzheimer, R.J. Fox, T. Schneider-Hohendorf, B.C. Kieseier, C.M. Monoranu, S.M. Staugaitis, W. Welch, S. Jilek, R.A. Du Pasquier, et al. 2012a. Fatal PML associated with efalizumab therapy: insights into integrin L2 in JC virus control. Neurology. 78:458-467, discussion:465. http://dx.doi.org/10.1212/WNL.0b013e3182478d4b
-
(2012)
Neurology
, vol.78
, pp. 458-467
-
-
Schwab, N.1
Ulzheimer, J.C.2
Fox, R.J.3
Schneider-Hohendorf, T.4
Kieseier, B.C.5
Monoranu, C.M.6
Staugaitis, S.M.7
Welch, W.8
Jilek, S.9
Du Pasquier, R.A.10
-
35
-
-
84857887383
-
Immunological and clinical consequences of treating a patient with natalizumab
-
Schwab, N., K.G. Hn, T. Schneider-Hohendorf, I. Metz, M.-P. Stenner, S. Jilek, R.A. Du Pasquier, R. Gold, S.G. Meuth, R.M. Ransohoff, et al. 2012b. Immunological and clinical consequences of treating a patient with natalizumab. Mult. Scler. 18:335-344. http://dx.doi.org/10.1177/1352458511421919
-
(2012)
Mult. Scler.
, vol.18
, pp. 335-344
-
-
Schwab, N.1
Hn, K.G.2
Schneider-Hohendorf, T.3
Metz, I.4
Stenner, M.-P.5
Jilek, S.6
Du Pasquier, R.A.7
Gold, R.8
Meuth, S.G.9
Ransohoff, R.M.10
-
36
-
-
84896903104
-
Immunology of relapse and remission in multiple sclerosis
-
Steinman, L. 2014. Immunology of relapse and remission in multiple sclerosis. Annu. Rev. Immunol. 32:257-281. http://dx.doi.org/10.1146/annurevimmunol-032713-120227
-
(2014)
Annu. Rev. Immunol.
, vol.32
, pp. 257-281
-
-
Steinman, L.1
-
37
-
-
53749105749
-
Effects of natalizumab treatment on Foxp3+ T regulatory cells
-
Stenner, M.-P., A. Waschbisch, D. Buck, S. Doerck, H. Einsele, K.V. Toyka, and H. Wiendl. 2008. Effects of natalizumab treatment on Foxp3+ T regulatory cells. PLoS ONE. 3:e3319. http://dx.doi.org/10.1371/journal.pone.0003319
-
(2008)
PLoS ONE
, vol.3
-
-
Stenner, M.-P.1
Waschbisch, A.2
Buck, D.3
Doerck, S.4
Einsele, H.5
Toyka, K.V.6
Wiendl, H.7
-
38
-
-
70350539771
-
Iatrogenic immunosuppression with biologics in MS: expecting the unexpected
-
Stüve, O., and H. Wiendl. 2009. Iatrogenic immunosuppression with biologics in MS: expecting the unexpected Neurology. 73:1346-1347. http://dx.doi.org/10.1212/WNL.0b013e3181beed38
-
(2009)
Neurology
, vol.73
, pp. 1346-1347
-
-
Stüve, O.1
Wiendl, H.2
-
39
-
-
33749588466
-
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis
-
Stüve, O., C.M. Marra, A. Bar-Or, M. Niino, P.D. Cravens, S. Cepok, E.M. Frohman, J.T. Phillips, G. Arendt, K.R. Jerome, et al. 2006a. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch. Neurol. 63:1383-1387. http://dx.doi.org/10.1001/archneur.63.10.1383
-
(2006)
Arch. Neurol.
, vol.63
, pp. 1383-1387
-
-
Stüve, O.1
Marra, C.M.2
Bar-Or, A.3
Niino, M.4
Cravens, P.D.5
Cepok, S.6
Frohman, E.M.7
Phillips, J.T.8
Arendt, G.9
Jerome, K.R.10
-
40
-
-
33646347610
-
Immune surveillance in multiple sclerosis patients treated with natalizumab
-
Stüve, O., C.M. Marra, K.R. Jerome, L. Cook, P.D. Cravens, S. Cepok, E.M. Frohman, J.T. Phillips, G. Arendt, B. Hemmer, et al. 2006b. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 59:743-747. http://dx.doi.org/10.1002/ana.20858
-
(2006)
Ann. Neurol.
, vol.59
, pp. 743-747
-
-
Stüve, O.1
Marra, C.M.2
Jerome, K.R.3
Cook, L.4
Cravens, P.D.5
Cepok, S.6
Frohman, E.M.7
Phillips, J.T.8
Arendt, G.9
Hemmer, B.10
-
41
-
-
84864431745
-
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter
-
Varrin-Doyer, M., C.M. Spencer, U. Schulze-Topphoff, P.A. Nelson, R.M. Stroud, B.A.C. Cree, and S.S. Zamvil. 2012. Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann. Neurol. 72:53-64. http://dx.doi.org/10.1002/ana.23651
-
(2012)
Ann. Neurol.
, vol.72
, pp. 53-64
-
-
Varrin-Doyer, M.1
Spencer, C.M.2
Schulze-Topphoff, U.3
Nelson, P.A.4
Stroud, R.M.5
Cree, B.A.C.6
Zamvil, S.S.7
-
42
-
-
84873087237
-
CD146, a multi-functional molecule beyond adhesion
-
Wang, Z., and X. Yan. 2013. CD146, a multi-functional molecule beyond adhesion. Cancer Lett. 330:150-162. http://dx.doi.org/10.1016/j.canlet.2012.11.049
-
(2013)
Cancer Lett
, vol.330
, pp. 150-162
-
-
Wang, Z.1
Yan, X.2
-
43
-
-
77951837763
-
Trafficking of immune cells in the central nervous system
-
Wilson, E.H., W. Weninger, and C.A. Hunter. 2010. Trafficking of immune cells in the central nervous system. J. Clin. Invest. 120:1368-1379. http://dx.doi.org/10.1172/JCI41911
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 1368-1379
-
-
Wilson, E.H.1
Weninger, W.2
Hunter, C.A.3
-
44
-
-
0026506799
-
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin
-
Yednock, T.A., C. Cannon, L.C. Fritz, F. Sanchez-Madrid, L. Steinman, and N. Karin. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 356:63-66. http://dx.doi.org/10.1038/356063a0
-
(1992)
Nature
, vol.356
, pp. 63-66
-
-
Yednock, T.A.1
Cannon, C.2
Fritz, L.C.3
Sanchez-Madrid, F.4
Steinman, L.5
Karin, N.6
-
45
-
-
34250180872
-
Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1
-
Zarbock, A., C.A. Lowell, and K. Ley. 2007. Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity. 26:773-783. http://dx.doi.org/10.1016/j.immuni.2007.04.011
-
(2007)
Immunity
, vol.26
, pp. 773-783
-
-
Zarbock, A.1
Lowell, C.A.2
Ley, K.3
|